Skip to content
Home/Companies/MedTech/Esaote Biomedica
Esaote Biomedica

Esaote Biomedica

MedTech·Italy·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Esaote Biomedica?

Esaote Biomedica is an Italian MedTech company, currently owned by Advent International since 2023.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Advent International
Investor
Advent International
Latin American Private Equity Fund VII · 2020 · Buyout

Key facts

HQItaly
SectorMedTech
Websitewww.esaote.com

More from Latin American Private Equity Fund VII

Other portfolio companies in the same fund.

3i – Implant Innovations Inc.
Active
HealthcareUS
Aareon Group GmbH
Active
SaaSGermany
ABC Supply
ABC Supply
Active
ConstructionUS
AccentCare
AccentCare
Active
HealthcareUS
Addiko Bank (formerly Hypo Group Alpe Adria)
Addiko Bank (formerly Hypo Group Alpe Adria)
Active
FinancialsAustria
Aditya Birla Capital
Aditya Birla Capital
Active
FinancialsIndia

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Esaote Biomedica?

Esaote Biomedica is currently owned by Advent International, through Latin American Private Equity Fund VII, since 2023.

When did Advent International acquire Esaote Biomedica?

Advent International acquired Esaote Biomedica in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue